Advancing Care for Patients Receiving CAR T-Cell Therapy: New Evidence and Opportunities for Oncology Pharmacy Practice

Download All
Review the latest strategies for optimizing care of patients with hematologic malignancies who are receiving CAR T-cells, including new data, clinical trials, and treatment guidelines. Learn from pharmacist experts by viewing a webcast with downloadable slides and review a commentary.
Craig Freyer, PharmD, BCOP
Andrew Lin, PharmD, BCOP

On-Demand Webcast

Watch this on-demand webcast from a recent HOPA satellite symposium on CAR T-cells for hematologic malignancies, including new data, recent approvals, and treatment guidelines.

Craig Freyer, PharmD, BCOP Andrew Lin, PharmD, BCOP Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 28, 2022 Expired: April 27, 2023
Provided by ProCE, LLC in partnership with Clinical Care Options, LLC.
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings